润都股份：关于布洛芬片获得药品注册证书的公告

Core Viewpoint - Rundu Co., Ltd. has received the drug registration certificate for Ibuprofen tablets from the National Medical Products Administration, indicating a significant step in expanding its pharmaceutical product offerings [2]. Group 1: Company Developments - Rundu Co., Ltd. announced the receipt of the drug registration certificate for Ibuprofen tablets, which are indicated for the relief of mild to moderate pain such as headaches, joint pain, migraines, toothaches, muscle pain, neuralgia, and dysmenorrhea [2]. - The Ibuprofen tablets are also indicated for fever caused by common colds or influenza, highlighting their potential market demand [2].